Corrigendum: Development of a Machine Learning Model for Optimal Applicator Selection in High-Dose-Rate Cervical Brachytherapy

by Kailyn Stenhouse, Kailyn Stenhouse, Michael Roumeliotis, Michael Roumeliotis, Michael Roumeliotis, Philip Ciunkiewicz, Robyn Banerjee, Robyn Banerjee, Svetlana Yanushkevich, Philip McGeachy, Philip McGeachy, Philip McGeachy
Published 2021-07-01

Development of a Machine Learning Model for Optimal Applicator Selection in High-Dose-Rate Cervical Brachytherapy

by Kailyn Stenhouse, Kailyn Stenhouse, Michael Roumeliotis, Michael Roumeliotis, Michael Roumeliotis, Philip Ciunkiewicz, Robyn Banerjee, Robyn Banerjee, Svetlana Yanushkevich, Philip McGeachy, Philip McGeachy, Philip McGeachy
Published 2021-03-01

Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma

by Rutvij A. Khanolkar, Harvey Quon, Kundan Thind, Michael Sia, Michael Roumeliotis, Siraj Husain, Philip McGeachy, Tyler Meyer, Kevin Martell
Published 2021-09-01